|
1
|
Kumar S, Malviya R and Meenakshi DU:
Overview of Women's Health. Women's Health: A Comprehensive Guide
to Common Health Issues in Women. Bentham Science Publishers; pp.
1–21. 2024
|
|
2
|
Sun D, Li H, Cao M, He S, Lei L, Peng J
and Chen W: Cancer burden in China: Trends, risk factors and
prevention. Cancer Biol Med. 17:879–895. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou L, Li Y, Wang H, Qin R, Han Z and Li
R: Global cervical cancer elimination: Quantifying the status,
progress, and gaps. BMC Med. 23:672025. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kombe Kombe AJ, Li B, Zahid A, Mengist HM,
Bounda GA, Zhou Y and Jin T: Epidemiology and burden of human
papillomavirus and related diseases, molecular pathogenesis, and
vaccine evaluation. Front Public Health. 8:5520282021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schiffman M, Castle PE, Jeronimo J,
Rodriguez AC and Wacholder S: Human papillomavirus and cervical
cancer. Lancet. 370:890–907. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liao S, Sun H and Xu C: YTH domain: A
family of N6-methyladenosine (m6A) readers.
Genomics Proteomics Bioinformatics. 16:99–107. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi R, Ying S, Li Y, Zhu L, Wang X and Jin
H: Linking the YTH domain to cancer: The importance of YTH family
proteins in epigenetics. Cell Death Dis. 12:3462021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma C, Liao S and Zhu Z: Crystal structure
of human YTHDC2 YTH domain. Biochem Biophys Res Commun.
518:678–684. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zaccara S, Ries RJ and Jaffrey SR:
Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell
Biol. 20:608–624. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mao Y, Dong L, Liu XM, Guo J, Ma H, Shen B
and Qian SB: m6A in mRNA coding regions promotes
translation via the RNA helicase-containing YTHDC2. Nat Commun.
10:53322019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tanabe A, Tanikawa K, Tsunetomi M, Takai
K, Ikeda H, Konno J, Torigoe T, Maeda H, Kutomi G, Okita K, et al:
RNA helicase YTHDC2 promotes cancer metastasis via the enhancement
of the efficiency by which HIF-1α mRNA is translated. Cancer Lett.
376:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He JJ, Li Z, Rong ZX, Gao J, Mu Y, Guan
YD, Ren XX, Zi YY, Liu LY, Fan Q, et al: m6A reader YTHDC2 promotes
radiotherapy resistance of nasopharyngeal carcinoma via activating
IGF1R/AKT/S6 signaling axis. Front Oncol. 10:11662020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang W, Sun B, Xia Y, Sun S and He C: RNA
N6-methyladenosine-related gene contribute to clinical prognostic
impact on patients with liver cancer. Front Genet. 11:3062020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu J, Wang D, Zhou J, Wang L, Zhang N,
Zhou L, Zeng J, Liu J and Yang M: N6-methyladenosine reader YTHDC2
and eraser FTO may determine hepatocellular carcinoma prognoses
after transarterial chemoembolization. Arch Toxicol. 95:1621–1629.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang W, Li J, Lin F, Guo J and Zhao J:
Identification of N 6-methyladenosine-related lncRNAs for patients
with primary glioblastoma. Neurosurg Rev. 44:463–470. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu Q, Xie X, Huang Y, Meng S, Li Y, Wang H
and Hu Y: N6-methyladenosine RNA methylation regulators contribute
to the progression of prostate cancer. J Cancer. 12:682–692. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao X and Cui L: Development and
validation of a m6A RNA methylation regulators-based signature for
predicting the prognosis of head and neck squamous cell carcinoma.
Am J Cancer Res. 9:2156–2169. 2019.PubMed/NCBI
|
|
18
|
Sun S, Han Q, Liang M, Zhang Q, Zhang J
and Cao J: Downregulation of m6A reader YTHDC2 promotes tumor
progression and predicts poor prognosis in non-small cell lung
cancer. Thorac Cancer. 11:3269–3279. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Benevolo M, Mottolese M, Marandino F,
Vocaturo G, Sindico R, Piperno G, Mariani L, Sperduti I, Canalini
P, Donnorso RP and Vocaturo A: Immunohistochemical expression of
p16INK4a is predictive of HR-HPV infection in cervical low-grade
lesions. Mod Pathol. 19:384–391. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Y, Fan P, Yang Y, Xu C, Huang Y, Li D,
Qing Q, Sun C and Zhou H: Human papillomavirus and human telomerase
RNA component gene in cervical cancer progression. Sci Rep.
9:159262019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wright JD, Matsuo K, Huang Y, Tergas AI,
Hou JY, Khoury-Collado F, St Clair CM, Ananth CV, Neugut AI and
Hershman DL: Prognostic performance of the 2018 international
federation of gynecology and obstetrics cervical cancer staging
guidelines. Obstet Gynecol. 134:49–57. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yan HF, Zou T, Tuo QZ, Xu S, Li H, Belaidi
AA and Lei P: Ferroptosis: Mechanisms and links with diseases. Sig
Transduct Target Ther. 6:492021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma L, Chen T, Zhang X, Miao Y, Tian X, Yu
K, Xu X, Niu Y, Guo S, Zhang C, et al: The m(6)A reader YTHDC2
inhibits lung adenocarcinoma tumorigenesis by suppressing
SLC7A11-dependent antioxidant function. Redox Biol. 38:1018012021.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang K, Yang Z, Yang Z, Du L, Zhou Y, Fu
S, Wang X, Li X, Liu D and He X: The m6A reader YTHDC2 promotes the
pathophysiology of temporal lobe epilepsy by modulating
SLC7A11-dependent glutamate dysregulation in astrocytes.
Theranostics. 14:5551–5570. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen SH, Song YY, Gan N, Wang PT, Yan K,
Wang SF, Zu YE and Peng XW: Human papillomavirus infection and
screening strategies. World J Clin Oncol. 16:1050552025. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Su H, Wang G, Wu L, Ma X, Ying K and Zhang
R: Transcriptome-wide map of m6A circRNAs identified in
a rat model of hypoxia mediated pulmonary hypertension. BMC
Genomics. 21:392020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mo X-B, Zhang Y-H and Lei S-F: Genome-wide
identification of N6-methyladenosine (m6A)
SNPs associated with rheumatoid arthritis. Front Genet. 9:2992018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
De Jesus DF, Zhang Z, Kahraman S, Brown
NK, Chen M, Hu J, Gupta MK, He C and Kulkarni RN: m6A
mRNA methylation regulates human β-cell biology in physiological
states and in type 2 diabetes. Nat Metab. 1:765–774. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Paris J, Morgan M, Campos J, Spencer GJ,
Shmakova A, Ivanova I, Mapperley C, Lawson H, Wotherspoon DA,
Sepulveda C, et al: Targeting the RNA m6A reader YTHDF2
selectively compromises cancer stem cells in acute myeloid
leukemia. Cell Stem Cell. 25:137–148.e6. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Q, Guo X, Li L, Gao Z, Su X, Ji M and
Liu J: N6-methyladenosine METTL3 promotes cervical
cancer tumorigenesis and Warburg effect through YTHDF1/HK2
modification. Cell Death Dis. 11:9112020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang H, Luo Q, Kang J, Wei Q, Yang Y, Yang
D, Liu X, Liu T and Yi P: YTHDF1 aggravates the progression of
cervical cancer through m6A-mediated up-regulation of
RANBP2. Front Oncol. 11:6503832021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tanabe A, Nakayama T, Kashiyanagi J,
Yamaga H, Hirohashi Y, Torigoe T, Satomi F, Shima H, Maeda H,
Kutomi G, et al: YTHDC2 promotes malignant phenotypes of breast
cancer cells. J Oncol. 2022:91889202022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qi X, Zhou J, Wang X, Shen Y, Cao Y, Jiang
L, Shen M, Zhang H, Wang T, Wei P, et al: HPV E6/E7-induced
acetylation of a peptide encoded by a long non-coding RNA inhibits
ferroptosis to promote the malignancy of cervical cancer. Adv Sci
(Weinh). 12:e24140182025. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wei E: Heterogeneity analysis of low-risk
HPV infection and high-risk HPV infection, HPV-positive and
HPV-negative cancers. Dissertation; LMU München: pp. 1–88. 2023
|
|
36
|
Song X, Zhu S, Chen P, Hou W, Wen Q, Liu
J, Xie Y, Liu J, Klionsky DJ, Kroemer G, et al: AMPK-mediated BECN1
phosphorylation promotes ferroptosis by directly blocking system
Xc-activity. Curr Biol. 28:2388–2399.e5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen H, Cao L, Han K, Zhang H, Cui J, Ma
X, Zhao S, Zhao C, Yin S, Yin S, et al: Patulin disrupts
SLC7A11-cystine-cysteine-GSH antioxidant system and promotes renal
cell ferroptosis both in vitro and in vivo. Food Chem Toxicol.
166:1132552022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Angeli JPF, Shah R, Pratt DA and Conrad M:
Ferroptosis inhibition: Mechanisms and opportunities. Trends
Pharmacol Sci. 38:489–498. 2017. View Article : Google Scholar : PubMed/NCBI
|
